Home Tags Magic mushrooms

Tag: magic mushrooms

Researchers think magic mushrooms could have the potential to treat depression

Recent research suggests the main psychoactive component in magic mushrooms, psilocybin, could be an alternative treatment for depression.
Magic mushrooms are categorized as hallucinogenics.

10 potential risks of taking ‘magic’ mushrooms

INSIDER consulted with two drug and addiction experts to learn more about the risks of taking magic mushrooms recreationally.

Denver could become the first US city to decriminalize psychedelic mushrooms

In Denver, a campaign trying to decriminalize hallucinogenic mushrooms has gathered enough signatures to place a measure on the ballot.

Oregon is closer than ever to becoming the first state to legalize ‘magic’ mushrooms

Oregon could be the first state to legalize psychedelic mushrooms. The secretary of state has approved language for a ballot initiative in 2020.

Evidence is mounting that psychedelic drugs can help treat diseases. Here are the most promising uses

There's been a resurgence of interest in psychedelic drugs' potential to treat conditions like depression. Research is beginning to lead to new treatments.

A team of Johns Hopkins researchers is calling for magic mushrooms to be made legally available as medicine

A group of scientists from Johns Hopkins University recently published an article in which they concluded that psilocybin, the active component of the psychedelic drug magic mushrooms, has a low risk of harm and should be legally available as medicine.

A new biotech company has raised $25 million to help unleash a ‘virgin market’ of psychedelic research

A new biotech company has raised $25 million to finance research on the effects of psychedelics like magic mushrooms on depression. Called Atai Life Sciences, the company is a leading investor in a Peter Thiel-backed company called Compass Pathways.

A startup backed by Peter Thiel has churned out 20,000 doses of magic mushrooms, and is making more

Compass Pathways has made two 250-gram batches of psilocybin, the active ingredient in magic mushrooms. Compass is testing the drug in Europe and North America and has funding from Peter Thiel to study psychedelics for depression.

Psychedelic drugs appear to fundamentally reorganize the brain — and they’re starting to turn into approved treatments

From magic mushrooms to ketamine, the drugs are being tested for their potential to treat an array of diseases and conditions that currently lack adequate treatments.